Plus, get calls on biotech, M&A and more.
Options trader Jon Najarian explains why these two stocks are experiencing heavy call volume.
Stocks declined as investors continued to consider future troubles in the euro zone and comments over the weekend by Federal Reserve Chairman Ben Bernanke indicating the central bank was willing to pump even more money into the economy. BofA and DuPont fell, which Cisco rose.
The Lightning Round is extended in this CNBC.com exclusive feature.
Trading in shares of the Janus Capital Group have been halted, apparently in anticipation of an announcement that federal authorities are looking at Janus as part of their insider trading dragnet.
This chat with the CEO should tell investors whether or not the stock is a buy ahead of an upcoming catalyst.
What follows is a roundup of corporate earnings reports for Thursday, Oct. 28.
Plus, get calls on tech, biotech, the rails and more.
Here's why you should keep a close eye on these six stocks.
On Tuesday, Cramer highlighted the action—and potential M&A activity—in the fight to cure hepatitis C.
Stocks closed higher after struggling to find direction much of the day amid light volume and ahead of a week filled with economic data. Chevron and Merck gained, HP fell.
Stocks are modestly higher after struggling to find direction much of the day amid light volume and ahead of a week filled with economic data. Merck and Chevron gained, HP fell.
What follows is a look at stocks in the S&P 500 displaying unusual volume in today's trading session.
Cramer makes the call on viewers' favorite stocks.
Large debt loads can weigh on a company's balance sheets, but a firm not having debt doesn’t necessarily mean it’s a money-making business. So are debt-free companies good investments right now? Doug Sandler, co-founder of Riverfront Investment Group, discussed his insights.
Some companies have a history of operating with low debt levels, and many choose to issue no debt at all. Here are 15 companies with zero debt as of Q2 2010.
Investors concerned about a double-dip can shield themselves with large-cap companies that have global reach and ample cash to withstand a slowdown.
Celgene now has a total of 17 ‘buy’ ratings and just 2 ‘hold’ ratings. Why are so many analysts so bullish?
Chatter that a major drug maker is looking to make at least one if not several acquisitions sent biotech surging. What must you know?
Corporations hold large amounts of cash for a variety of reasons. So, which S&P 500 companies are the most cash-rich? Click to find out!